Grail rallies 30% in wake of Quest agreement
Grail (GRAL) stock shot up 33% Thursday, the day after the company announced a partnership with Quest (DGX) to expand provider access to Grail's Galleri multi-cancer early detection test.
Companion Diagnostics Market Trends 2019-2024 and Forecast to 2034 - Rising Number of Targeted Therapies Driving the $8.75 Billion Industry
Companion Diagnostics Market Companion Diagnostics Market Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Companion ...
11 Stocks Jeff Bezos Is Buying
Jeff Bezos has come a long way in the past 30 years — as has the company he founded in 1994, Amazon.com Inc. (ticker: AMZN). Amazon ranks as the No. 2 company in the world by ...